Does REBAMIPIDE Cause Interstitial lung disease? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Interstitial lung disease have been filed in association with REBAMIPIDE. This represents 3.3% of all adverse event reports for REBAMIPIDE.
14
Reports of Interstitial lung disease with REBAMIPIDE
3.3%
of all REBAMIPIDE reports
3
Deaths
12
Hospitalizations
How Dangerous Is Interstitial lung disease From REBAMIPIDE?
Of the 14 reports, 3 (21.4%) resulted in death, 12 (85.7%) required hospitalization, and 5 (35.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REBAMIPIDE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does REBAMIPIDE Cause?
Hepatic function abnormal (30)
Drug eruption (28)
Nausea (26)
Rash (26)
Vomiting (22)
Pyrexia (19)
Anaemia (18)
Diarrhoea (18)
Platelet count decreased (18)
Pruritus (18)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which REBAMIPIDE Alternatives Have Lower Interstitial lung disease Risk?
REBAMIPIDE vs REBETOL
REBAMIPIDE vs REBIF
REBAMIPIDE vs REBOXETINE
REBAMIPIDE vs RECLAST
REBAMIPIDE vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E